• Text size
  • Send this article to a friend
  • Print this article

Braveheart leads funding round for cardiovascular technology firm

Braveheart Investment Group has led a further funding round for Tayside Flow Technologies, which makes devices to treat cardiovascular disorders.

Custom byline text: 
Douglas Hamilton

The £300,000 package includes money from Braveheart clients, Scottish Enterprise, Quayle Munro Holdings and other private investors.